Adverum Biotechnologies logo
Adverum Biotechnologies
ADVM | NASDAQ
Chart Builder DCF Calculator
$4.36
$0.00 (0.00%)
At close: Dec 9, 2025, 4:00 PM ET

Adverum Biotechnologies Cash Flow Statement

Cash flow statement explained
Fiscal Year
Period Ending
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
FY 2019
Dec 31, 2019
-130.93M -122.12M -154.54M -145.54M -117.51M -64.49M
3.65M 5.64M 6.53M 4.65M 4.16M 1.57M
14.35M 17.57M 20.08M 25.19M 20.39M 9.9M
1.17M -8.14M 19.04M 5.67M 11.14M 5.71M
19.55M 16.51M -51K -25K 75K 58K
– – – 3.83M 863K -1.27M
911K -8.51M 19.89M 4.06M 12.73M 5.06M
-92.46M -90.9M -108.09M -107.83M -79.29M -49.17M
-388K -808K -11.82M -15.12M -11.84M -19.25M
– – – – – –
-101.9M -36.72M -104.36M -407.51M -570.39M -197.34M
60.4M 134.4M 257.9M 501.35M 302.06M 148.52M
– – – – – –
-41.89M 96.88M 141.72M 78.71M -280.17M -68.07M
– – – -240K -61K -112K
– – – – – –
– – – – – –
642K -420K – 952K 11.74M 2.41M
120M 69K 607K 2.4M 355.99M 28.19M
-14.35M 6.04M 34.24M -26.73M -3.47M -89.05M
-92.85M -91.71M -119.91M -122.95M -91.14M -68.42M
-107.2M -109.28M -139.99M -148.15M -111.53M -78.32M
-388K – -11.82M – -11.84M -19.25M
– -808K – -15.12M – –
-92.85M -90.9M -119.91M -107.83M -91.14M -68.42M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.